Concepedia

Search: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients with Hepatocellular Carcinoma (HCC)

Andrew X. Zhu, Olivier Rosmorduc, Jenny Evans, Paul J. Ross, Antonino Santoro, F.J. Carrilho, Marine Leberre, Maj‐Britt Jensen, Gudrun Meinhardt, Yu-chen Kang

Annals of Oncology · 2012 · 49 citations · 0 references

Open access

Concepts

MedicineOncologyPharmacologyCancer PharmacologyOncology PharmacotherapyHepatocellular CarcinomaHepatocellular Carcinoma PharmacotherapyLiver CancerLiver MetastasisMalignant NeoplasmsErlotinib TherapyHepatic TumorsHepatocellular Carcinoma TreatmentLiver Metastases TreatmentLiver Tumor TherapyPlacebo-controlled Efficacy AssessmentSorafenib Therapy